Serum Albumin and Glycemic Variability Could Contribute to Diabetic Retinopathy Progression by Regulating Chronic...

Area of Science:

• Endocrinology and Metabolism
• Ophthalmology
• Surgical Research

Background:

• Type 2 diabetes (T2DM) patients often face diabetic retinopathy (DR) progression despite glycemic control.
• Bariatric surgery is a T2DM treatment, but its impact on DR progression needs further investigation.

Purpose of the Study:

• To identify clinical predictors of DR progression in T2DM patients post-bariatric surgery.
• To explore the relationship between serum albumin, inflammatory markers, and DR progression.

Main Methods:

• Retrospective analysis of T2DM patients from a bariatric surgery trial.
• Data collection included DR screening and blood markers at baseline and 5 years post-surgery.
• Analysis of plasma cytokine concentrations, including IL-6 and IL-1β.

Main Results:

• Postoperative decrease in serum albumin was a significant predictor of DR progression (OR=0.461, p=0.039).
• Lower albumin levels correlated with increased IL-6 and IL-1β, suggesting NLRP3 inflammasome involvement.
• Greater month-to-month HbA1c variability was observed in patients with DR progression (p=0.0115).

Conclusions:

• Decreased serum albumin and increased glycemic variability may drive DR progression via inflammatory pathways.
• The NLRP3 inflammasome pathway is implicated in DR development post-bariatric surgery.
• Further research is required to elucidate the precise role of albumin in DR progression.